Daily FNArena News

Enthusiasm waned again in the uranium spot market this week while one broker suggests no material upside for prices for the next five years.

The September Australian Investors’ Sentiment Survey revealed an uptick in general optimism with investors cautiously re-allocating funds into the local share market.

Analysts have welcomed several signs of a recovery in Australian housing but are yet to be convinced the rebound is robust.

Michael Gable of Fairmont Equities suggests Sonic Healthcare is shaping up as a solid longer term proposition.

Businesses surveyed by Dun & Bradstreet during September were far more upbeat than they have been for some time.

A wrap of the day’s activity on the Australian stock market.

Volatility eases in coal and iron ore, price forecasts are eased across a number of metals and production forecasts are ramped. Then there’s productivity.

FNArena provides a weekly update of Australian listed corporate bond issues, current pricing and yield data.

Sonic Healthcare will acquire five laboratories in Germany and brokers find the expansion has a lot of merit.

Weekly update on recommendation, target price, and earnings forecast changes.